Counterfeit and illicitly traded health products remained a persistent concern in Türkiye throughout 2025, as reflected both in enforcement statistics and in external reporting on supply chain integrity. Despite the legal prohibition on the online sale of pharmaceutical products, there has been a noticeable increase in the circulation of counterfeit medicines through online channels, alongside growing reports of products being illicitly exported from Türkiye to foreign…
»
The prices of pharmaceuticals to be launched on the market are determined in accordance with the Decision on the Pricing of Medicinal Products for Human Use (“Decision”) and the Communiqué on the Pricing of Medicinal Products for Human Use (“Communiqué”) dated 29 September 2017, published by the Ministry of Health, which has been authorised to regulate this area.
The Decision foresees a reference pricing system in which the lowest wholesaler price for the relevant product in…
»
NPPs operate as special import regimes that enable access to medicines that are either not authorised in Türkiye or are temporarily unavailable on the domestic market, upon the request of a treating physician. Fundamentally designed to address urgent or exceptional patient needs, the NPP framework has gradually evolved into a more structured and regulated supply mechanism.
A significant step in this evolution was the entry into force of the Regulation on the Importation of…
»
Alternative reimbursement models in Türkiye provide pathways for innovative medicines to gain coverage outside standard pricing rules, allowing the Social Security Institution (“SSI”) to negotiate terms such as discounts, budget caps, or other arrangements. These models, formalised under the 2016 Regulation on Alternative Reimbursement and updated in 2023, aim to improve patient access while managing healthcare expenditures.
The Regulation on Alternative Reimbursement…
»
In a recent decision of the Turkish Court of Cassation (Merit No. 2024/6138, Decision No. 2025/3800), the Court conducted a holistic comparison between a globally renowned energy drink brand and a motor oil brand, examining all aspects, from the similarity of the goods to the colors and figurative elements used in the disputed trademarks.
Background
The dispute involved, on the one side, the plaintiff’s well-known marks in the energy drinks sector – the word mark “MONSTER…
»
This article examines a lawsuit concerning the use of a trademark, after it was registered in Türkiye by a third party, with the aim of threatening infringement proceedings against the company that is the rightful owner of the mark and evaluates how the courts protect the genuine rights holder against bad faith registration.
Background
The dispute concerned the bad faith registration of a trademark that had previously been registered in Türkiye in the name of Stiefel…
»
